glycine has been researched along with Graves Ophthalmopathy in 2 studies
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ida, Y | 2 |
| Ichioka, H | 2 |
| Furuhashi, M | 1 |
| Hikage, F | 2 |
| Watanabe, M | 2 |
| Umetsu, A | 1 |
| Ohguro, H | 2 |
2 other studies available for glycine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.
Topics: Cell Size; Cytokines; Endoplasmic Reticulum Stress; Extracellular Matrix; Fibroblasts; Gene Expressi | 2021 |
Prostaglandin F2α and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts.
Topics: Bimatoprost; Cell Culture Techniques; Dinoprost; Extracellular Matrix Proteins; Fibroblasts; Gene Ex | 2021 |